Latest Breaking News On - Erez aminov - Page 1 : comparemela.com

Mira Pharmaceuticals Announces DEA Rules MIRA-55, a Novel Oral Pharmaceutical Marijuana Analog, Is Not Classified as a Controlled Substance

Ruling removes potential complications for manufacturing, pre-clinical development, IND submission, clinical development, and ultimately commercialization. MIAMI, May 29, 2024 /PRNewswire/ MIRA.

United statesNew yorkErez aminovItzchak angelMira pharmaceuticals announcesSecurities exchangePharmaceuticals incUs drug enforcement administrationEnforcement administrationControlled substance actNot classifiedControlled substanceAnti anxiety effectsIntoxicating effectsChief scientific advisorControlled substances act

MIRA Pharmaceuticals in Discussions with Memorial Sloan Kettering to Collaborate on Preclinical Cancer Pain Model Utilizing The Company s Novel Oral Ketamine Analog

Ketamir-2, the Company s novel oral ketamine analog in development, aims to provide a safe and effective alternative for managing cancer pain and associated depression MIAMI, May 21, 2024.

United statesErez aminovAmitabh gulatiItzchak angelSloan ketteringPharmaceuticals incSecurities exchangeBoard member of cancer pain research consortiumNational cancer instituteSloan kettering cancer centerPharmaceuticals in discussionsDrug administrationPharmaseed ltdSloan kettering instituteMemorial sloan kettering cancer centerUs drug enforcement administration

Mira Pharmaceuticals Advances Preclinical Trials T

MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the treatment of neurologic and

United statesItzchak angelErez aminovScientific advisor of mira pharmaceuticalsTraumatic stress disorder treatment market researchPharmaseed ltdUs drug enforcement administrationNational institutes of healthMira pharmaceuticals advances preclinical trialsMarket researchPharmaceuticals incBiotrial incAmira pharmaceuticalsDrug administrationInvestigational new drug applicationPreclinical trials

Mira Pharma (MIRA) Reports Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission

Mira Pharma (MIRA) Reports Encouraging Preclinical Results Advancing Ketamir-2 Towards Potential Year-End IND Submission
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Erez aminovItzchak angelTraumatic stress disorder treatment market researchMarket researchAmira pharmaceuticalsDrug administrationAmira pharmaceuticals incFrontage laboratoriesInvestigational new drug applicationScientific advisorClinical psychiatry

MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

AI Simulation on MIRA1a Showcases Significant Potential Advantages Over Plant-Based Medical Marijuana Related to Anxiety, Appetite and Cognition BALTIMORE, Dec. 4, 2023 /PRNewswire/ MIRA.

Erez aminovAdam kaplinDrug administrationUs drug enforcement administrationPharmaceuticals incChief executive officerInvestigational new drugPossible breakthroughAnxiety reliefAppetite concernsChief scientific officerEnforcement administrationControlled substances actRegistration statement